125
Views
77
CrossRef citations to date
0
Altmetric
Research Article

Studies on the transport pathway of PBCA nanoparticles in ocular tissues

, &
Pages 497-504 | Received 04 Feb 1991, Accepted 18 Feb 1991, Published online: 27 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Javed Ali, Mohd Fazil, Mohd Qumbar, Nazia Khan & Asgar Ali. (2016) Colloidal drug delivery system: amplify the ocular delivery. Drug Delivery 23:3, pages 700-716.
Read now
Faezeh Tashakori-Sabzevar & Seyed Ahmad Mohajeri. (2015) Development of ocular drug delivery systems using molecularly imprinted soft contact lenses. Drug Development and Industrial Pharmacy 41:5, pages 703-713.
Read now
Lisa C du Toit, Viness Pillay, Yahya E Choonara, Thirumala Govender & Trevor Carmichael. (2011) Ocular drug delivery – a look towards nanobioadhesives. Expert Opinion on Drug Delivery 8:1, pages 71-94.
Read now
Evren H. Gökçe, Giuseppina Sandri, Sait Eğrilmez, M. Cristina Bonferoni, Tamer Güneri & Carla Caramella. (2009) Cyclosporine A-Loaded Solid Lipid Nanoparticles: Ocular Tolerance and In Vivo Drug Release in Rabbit Eyes. Current Eye Research 34:11, pages 996-1003.
Read now
Patrizia Paolicelli, Maria de la Fuente, Alejandro Sánchez, Begoña Seijo & María José Alonso. (2009) Chitosan nanoparticles for drug delivery to the eye. Expert Opinion on Drug Delivery 6:3, pages 239-253.
Read now
Yasmin Sultana, M Aqil, Asgar Ali & Abdus Samad. (2007) Advances in the topical ocular drug delivery. Expert Review of Ophthalmology 2:2, pages 309-323.
Read now
Christine Vauthier, Denis Labarre & Gilles Ponchel. (2007) Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery. Journal of Drug Targeting 15:10, pages 641-663.
Read now
Laura Rabinovich-Guilatt, Patrick Couvreur, Gregory Lambert & Catherine Dubernet. (2004) Cationic Vectors in Ocular Drug Delivery. Journal of Drug Targeting 12:9-10, pages 623-633.
Read now
Indu Pal Kaur & Meenakshi Kanwar. (2002) Ocular Preparations: The Formulation Approach. Drug Development and Industrial Pharmacy 28:5, pages 473-493.
Read now
C. A. Le Bourlais, F. Chevanne, B. Turlin, L. Acar, H. Zia, P. A. Sado, T. E. Needham & R. Leverge. (1997) Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study. Journal of Microencapsulation 14:4, pages 457-467.
Read now
. (1992) Literature Alerts. Journal of Microencapsulation 9:3, pages 393-414.
Read now

Articles from other publishers (66)

Julio C. Cuggino, Luis I. Tártara, Luis M. Gugliotta, Santiago D. Palma & Cecilia I. Alvarez Igarzabal. (2021) Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy. Materials Science and Engineering: C 118, pages 111383.
Crossref
N.J. Vignesh, P. Shenbaga Velu & Navasingh Rajesh Jesudoss Hynes. 2021. Nanomedicine Manufacturing and Applications. Nanomedicine Manufacturing and Applications 209 220 .
Liwen Wang, Shan Luo, Hongyan Xu, Xiaoxiao Wu, Pengyan Hao, Yagang Zhang, Wenjuan Huang & Xingjie Zan. (2020) Evaluation of His 6 -Metal Assemblies as a Drug Delivery Vehicle in the Treatment of Anterior Segment Disease Using a Corneal Inflammation Model . ACS Biomaterials Science & Engineering 6:7, pages 4012-4023.
Crossref
Abhishek K. Sah, Nagendra Bhuwane, Ishwari Choudhary, Shweta Ramkar & Preeti K. Suresh. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health 207 226 .
Manu Sharma, Ankita Deohra, Kakarla Raghava Reddy & Veera Sadhu. 2019. Nanotechnology. Nanotechnology 93 114 .
Julieta C. Imperiale, Gabriela B. Acosta & Alejandro Sosnik. (2018) Polymer-based carriers for ophthalmic drug delivery. Journal of Controlled Release 285, pages 106-141.
Crossref
Rinda Bachu, Pallabitha Chowdhury, Zahraa Al-Saedi, Pradeep Karla & Sai Boddu. (2018) Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases. Pharmaceutics 10:1, pages 28.
Crossref
Dileep R. Janagam, Linfeng Wu & Tao L. Lowe. (2017) Nanoparticles for drug delivery to the anterior segment of the eye. Advanced Drug Delivery Reviews 122, pages 31-64.
Crossref
Tianyang Zhou, Ling Zhu, Huiyun Xia, Jijun He, Susu Liu, Siyu He, Liya Wang & Junjie Zhang. (2017) Micelle carriers based on macrogol 15 hydroxystearate for ocular delivery of terbinafine hydrochloride: In vitro characterization and in vivo permeation. European Journal of Pharmaceutical Sciences 109, pages 288-296.
Crossref
Ameeduzzafar Zafar, Javed Ahmad, Richard T. Addo & Sohail Akhter. 2016. Ocular Drug Delivery: Advances, Challenges and Applications. Ocular Drug Delivery: Advances, Challenges and Applications 131 163 .
Ameeduzzafar Zafar, Javed Ahmad, Sohail Akhter & Richard T. Addo. 2016. Ocular Drug Delivery: Advances, Challenges and Applications. Ocular Drug Delivery: Advances, Challenges and Applications 75 99 .
Rutika Godse, Kavita Singh, Agnivesh Shrivastava & Ujwala Shinde. 2016. Nano-Biomaterials For Ophthalmic Drug Delivery. Nano-Biomaterials For Ophthalmic Drug Delivery 351 387 .
Harmeet Kaur & Jasbir Singh. 2015. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials 5858 5880 .
Josep Sanchís, Marinella Farré & Damià Barceló. 2015. Nanomaterials in the Environment. Nanomaterials in the Environment 129 157 .
S. Reimondez-Troitiño, N. Csaba, M.J. Alonso & M. de la Fuente. (2015) Nanotherapies for the treatment of ocular diseases. European Journal of Pharmaceutics and Biopharmaceutics 95, pages 279-293.
Crossref
I.M. Carvalho, C.S. Marques, R.S. Oliveira, P.B. Coelho, P.C. Costa & D.C. Ferreira. (2015) Sustained drug release by contact lenses for glaucoma treatment—A review. Journal of Controlled Release 202, pages 76-82.
Crossref
Patricia I. Dolez. 2015. Nanoengineering. Nanoengineering 607 635 .
Patricia I. Dolez & Maximilien Debia. 2015. Nanoengineering. Nanoengineering 427 484 .
José AriasCornelia Vasile, Ana Oprea, Manuela Nistor & Anca-Maria Cojocariu. 2014. Nanotechnology and Drug Delivery, Volume One. Nanotechnology and Drug Delivery, Volume One 28 80 .
Umang Shah, Garima Joshi & Krutika Sawant. (2014) Improvement in antihypertensive and antianginal effects of felodipine by enhanced absorption from PLGA nanoparticles optimized by factorial design. Materials Science and Engineering: C 35, pages 153-163.
Crossref
Farhan Ahmad, Sohail Akhter, Mohammad Ahmad, Farshad Ramazani, Mohammad Samim, Musarrat Warsi, Mohammad Anwar & Ziyaur Rahman. 2013. Chitin and Chitosan Derivatives. Chitin and Chitosan Derivatives 317 336 .
Rajesh Katara & Dipak K. Majumdar. (2013) Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery. Colloids and Surfaces B: Biointerfaces 103, pages 455-462.
Crossref
Kris Hermans, Dave Van den Plas, Arnout Everaert, Wim Weyenberg & Annick Ludwig. (2012) Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 82:1, pages 27-35.
Crossref
Himanshu Gupta & Mohammed Aqil. (2012) Contact lenses in ocular therapeutics. Drug Discovery Today 17:9-10, pages 522-527.
Crossref
Burçin Yavuz, Sibel Bozdağ Pehlivan & Nurşen Ünlü. (2012) An Overview on Dry Eye Treatment: Approaches for Cyclosporin A Delivery. The Scientific World Journal 2012, pages 1-11.
Crossref
Jaime Salazar, Oliver Heinzerling, Rainer H. Müller & Jan P. Möschwitzer. (2011) Process optimization of a novel production method for nanosuspensions using design of experiments (DoE). International Journal of Pharmaceutics 420:2, pages 395-403.
Crossref
Zhe Liu, Twan Lammers, Josef Ehling, Stanley Fokong, Jörg Bornemann, Fabian Kiessling & Jessica Gätjens. (2011) Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 32:26, pages 6155-6163.
Crossref
Koichi Baba, Yuji Tanaka, Akira Kubota, Hitoshi Kasai, Shunji Yokokura, Hachiro Nakanishi & Kohji Nishida. (2011) A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye. Journal of Controlled Release 153:3, pages 278-287.
Crossref
Hamdy Abdelkader, Sayed Ismail, Amal Kamal & Raid G. Alany. (2011) Design and Evaluation of Controlled-Release Niosomes and Discomes for Naltrexone Hydrochloride Ocular Delivery. Journal of Pharmaceutical Sciences 100:5, pages 1833-1846.
Crossref
Pilar Calvo, María J Alonso, José L Vila-Jato & Joseph R Robinson. (1996) Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers. Journal of Pharmacy and Pharmacology 48:11, pages 1147-1152.
Crossref
Robert A Yokel & Robert C MacPhail. (2011) Engineered nanomaterials: exposures, hazards, and risk prevention. Journal of Occupational Medicine and Toxicology 6:1, pages 7.
Crossref
Yolanda Diebold & Margarita Calonge. (2010) Applications of nanoparticles in ophthalmology. Progress in Retinal and Eye Research 29:6, pages 596-609.
Crossref
Swarnali Das, Preeti K. Suresh & Rohitas Desmukh. (2010) Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine 6:2, pages 318-323.
Crossref
Swarnali Das & Preeti K. Suresh. (2010) Drug delivery to eye: Special reference to nanoparticle.. International Journal of Drug Delivery 2:1, pages 12-21.
Crossref
Shayne Cox GadSophia G. Antimisiaris, Paraskevi Kallinteri & Dimitrios G. Fatouros. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
María José Alonso & Alejandro Sánchez. (2003) The potential of chitosan in ocular drug delivery. Journal of Pharmacy and Pharmacology 55:11, pages 1451-1463.
Crossref
M. Niu, K. Shi, Y. Sun, J. Wang & F. Cui. (2008) Preparation of CyA-loaded solid lipid nanoparticles and application on ocular preparations. Journal of Drug Delivery Science and Technology 18:4, pages 293-297.
Crossref
Denise K. Chun, Aron Shapiro & Mark B. Abelson. 2008. Albert &amp Jakobiec's Principles &amp Practice of Ophthalmology. Albert &amp Jakobiec's Principles &amp Practice of Ophthalmology 179 192 .
Samuel R. Pygall, Joanne Whetstone, Peter Timmins & Colin D. Melia. (2007) Pharmaceutical applications of confocal laser scanning microscopy: The physical characterisation of pharmaceutical systems. Advanced Drug Delivery Reviews 59:14, pages 1434-1452.
Crossref
Basavaraj K. Nanjawade, F.V. Manvi & A.S. Manjappa. (2007) RETRACTED: In situ-forming hydrogels for sustained ophthalmic drug delivery. Journal of Controlled Release 122:2, pages 119-134.
Crossref
C.C. Li & A. Chauhan. (2007) Ocular transport model for ophthalmic delivery of timolol through p-HEMA contact lenses. Journal of Drug Delivery Science and Technology 17:1, pages 69-79.
Crossref
E. Vega, M.A. Egea, O. Valls, M. Espina & M.L. García. (2006) Flurbiprofen Loaded Biodegradable Nanoparticles for Ophtalmic Administration. Journal of Pharmaceutical Sciences 95:11, pages 2393-2405.
Crossref
Catarina Pinto Reis, Ronald J. Neufeld, António J. Ribeiro & Francisco Veiga. (2006) Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomedicine: Nanotechnology, Biology and Medicine 2:2, pages 53-65.
Crossref
Chi-Chung Li & Anuj Chauhan. (2006) Modeling Ophthalmic Drug Delivery by Soaked Contact Lenses. Industrial & Engineering Chemistry Research 45:10, pages 3718-3734.
Crossref
Aniruddha Amrite & Uday Kompella. 2006. Nanoparticle Technology for Drug Delivery. Nanoparticle Technology for Drug Delivery.
Kathleen Dillen, Wim Weyenberg, Jo Vandervoort & Annick Ludwig. (2004) The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 58:3, pages 539-549.
Crossref
R Alvarez-Román, A Naik, Y.N Kalia, H Fessi & R.H Guy. (2004) Visualization of skin penetration using confocal laser scanning microscopy. European Journal of Pharmaceutics and Biopharmaceutics 58:2, pages 301-316.
Crossref
Kathleen Dillen, Jo Vandervoort, Guy Van den Mooter, Loes Verheyden & Annick Ludwig. (2004) Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. International Journal of Pharmaceutics 275:1-2, pages 171-187.
Crossref
J Vandervoort & A Ludwig. (2004) Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. European Journal of Pharmaceutics and Biopharmaceutics 57:2, pages 251-261.
Crossref
Indu P. Kaur, Alka Garg, Anil K. Singla & Deepika Aggarwal. (2004) Vesicular systems in ocular drug delivery: an overview. International Journal of Pharmaceutics 269:1, pages 1-14.
Crossref
E Fattal, D Labarre & C Vauthier. 2003. Tissue Engineering And Novel Delivery Systems. Tissue Engineering And Novel Delivery Systems.
F Lallemand, O Felt-Baeyens, K Besseghir, F Behar-Cohen & R Gurny. (2003) Cyclosporine A delivery to the eye: A pharmaceutical challenge. European Journal of Pharmaceutics and Biopharmaceutics 56:3, pages 307-318.
Crossref
Christine Vauthier, Catherine Dubernet, Elias Fattal, Huguette Pinto-Alphandary & Patrick Couvreur. (2003) Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Advanced Drug Delivery Reviews 55:4, pages 519-548.
Crossref
Gangadhar Sunkara & Uday Kompella. 2003. Ophthalmic Drug Delivery Systems, Second Edition. Ophthalmic Drug Delivery Systems, Second Edition 13 58 .
Murali Kothuri, Swathi Pinnamaneni, Nandita Das & Sudip Das. 2003. Ophthalmic Drug Delivery Systems, Second Edition. Ophthalmic Drug Delivery Systems, Second Edition 437 466 .
J Vandervoort & A Ludwig. (2002) Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. International Journal of Pharmaceutics 238:1-2, pages 77-92.
Crossref
G Barratt, G Couarraze, P Couvreur, C Dubernet, E Fattal, R Gref, D Labarre, P Legrand, G Ponchel & C Vauthier. 2001. Polymeric Biomaterials, Revised and Expanded. Polymeric Biomaterials, Revised and Expanded.
Massimo Fresta, Giacomo Fontana, Claudio Bucolo, Gennara Cavallaro, Gaetano Giammona & Giovanni Puglisi. (2001) Ocular Tolerability and In Vivo Bioavailability of Poly(ethylene glycol) (PEG)‐Coated Polyethyl‐2‐Cyanoacrylate Nanosphere‐Encapsulated Acyclovir. Journal of Pharmaceutical Sciences 90:3, pages 288-297.
Crossref
Chrystèle Le Bourlais, Liliane Acar, Hosein Zia, Pierre A. Sado, Thomas Needham & Roger Leverge. (1998) Ophthalmic drug delivery systems—Recent advances. Progress in Retinal and Eye Research 17:1, pages 33-58.
Crossref
Nimit Worakul & Joseph R. Robinson. (1997) Ocular pharmacokinetics/pharmacodynamics. European Journal of Pharmaceutics and Biopharmaceutics 44:1, pages 71-83.
Crossref
Pilar Calvo, José L. Vila-Jato & María J. Alonso. (1996) Comparative in vitro Evaluation of Several Colloidal Systems, Nanoparticles, Nanocapsules, and Nanoemulsions, as Ocular Drug Carriers. Journal of Pharmaceutical Sciences 85:5, pages 530-536.
Crossref
Andreas Zimmer & Jörg Kreuter. (1995) Microspheres and nanoparticles used in ocular delivery systems. Advanced Drug Delivery Reviews 16:1, pages 61-73.
Crossref
Annette Katharina Zimmer, Horst Zerbe & Jörg Kreuter. (1994) Evaluation of pilocarpine-loaded albumin particles as drug delivery systems for controlled delivery in the eye I. In vitro and in vivo characterisation. Journal of Controlled Release 32:1, pages 57-70.
Crossref
K. Langer, E. Seegmüller, A. Zimmer & J. Kreuter. (1994) Characterisation of polybutylcyanoarylate nanoparticles: I. Quantification of PCBA polymer and dextrans. International Journal of Pharmaceutics 110:1, pages 21-27.
Crossref
. (2008) Bibliography on confocal microscopy and its applications. Scanning 16:1, pages 33-56.
Crossref
CANDIDA LOSA, MARIA J. ALONSO, JOSÉ L. VILA, FRANCISCO ORALLO, JESUS MARTINEZ, JOSÉ A. SAAVEDRA & JOSÉ C. PASTOR. (1992) Reduction of Cardiovascular Side Effects Associated with Ocular Administration of Metipranolol by Inclusion in Polymeric Nanocapsules. Journal of Ocular Pharmacology and Therapeutics 8:3, pages 191-198.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.